在癌症中准转录性循环素依赖性基因酶
Aleksandra Kolodziejczyk1, Piotr Sicinski1
1Dana-Farber Cancer Institute, Boston, MA, United States.
Molecular cancer therapeutics
|July 15, 2025
概括
转录环素依赖激酶 (tCDK) 对癌症生长至关重要. 抑制tCDKs在临床前癌症模型中表现有希望,通过选择性向癌细胞,提供了一条新的治疗途径.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 循环素依赖激酶 (CDK) 对于细胞循环和转录至关重要.
- 失调的CDK在癌症中很常见.
- 转录性CDK (tCDK) 正在成为关键的治疗点.
研究的目的:
- 探索在癌症治疗中准转录性CDK (tCDK) 的治疗潜力.
- 要突出tCDKs在瘤生长和存活中的作用.
- 讨论tCDK抑制剂开发的挑战和未来方向.
主要方法:
- 对tCDK抑制剂的临床前研究的审查.
- 分析癌细胞中tCDK选择性背后的机制.
- 探索新兴策略,如针对性蛋白质降解.
主要成果:
- tCDK 抑制剂在临床前癌症模型中显示出有效性.
- 由于癌细胞对转录的高度依赖 (基因成),观察到选择性.
- tCDKs调节关键过程,如RNA聚合酶激活和转录延长.
结论:
- 向tCDK是针对具有高转录活性的癌症的一个有希望的策略.
- 挑战包括抑制剂的特异性和理解更广泛的生物影响.
- 需要进一步的研究和新的策略,如针对性降解,用于临床翻译.
更多相关视频
相关概念视频
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...